6CHF
15.15 MCHF
147.95 MCHF
638.35 K
About IVF HARTMANN N
Sector
Industry
CEO
Claus Martini
Website
Headquarters
Neuhausen
Employees (FY)
304
Founded
1871
ISIN
CH0187624256
FIGI
BBG00JYV5S41
IVF HARTMANN Holding AG engages in the business of producing and distributing medical consumer products. It operates through the following segments: Wound Care, Incontinence Management, Infection Management, and Other Group Activities. The Wound Care segment includes modern and traditional wound care products, as well as the first aid product area. The Incontinence Management segment offers products of incontinence, patient hygiene, and medical skin care product range. The Infection Management segment includes disinfectants, surgical drapes, surgical clothing and gloves, disposable surgical instruments, and customer-specific sets. The Other Group Activities segment is involved in various cotton wool, personal care, housekeeping, hygiene products, and product area of self-diagnostics. The company was founded in 1871 and is headquartered in Neuhausen, Switzerland.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 0QQM is 142 CHF — it has increased by 0.71% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange IVF HARTMANN HOLDING AG CHF1.75 (REGD) stocks are traded under the ticker 0QQM.
0QQM stock is 0.70% volatile and has beta coefficient of 0.33. Check out the list of the most volatile stocks — is IVF HARTMANN HOLDING AG CHF1.75 (REGD) there?
Yes, you can track IVF HARTMANN HOLDING AG CHF1.75 (REGD) financials in yearly and quarterly reports right on TradingView.
0QQM stock has risen by 0.71% compared to the previous week, the month change is a 4.41% rise, over the last year IVF HARTMANN HOLDING AG CHF1.75 (REGD) has showed a 25.11% increase.
0QQM net income for the last quarter is 8.11 M CHF, while the quarter before that showed 7.04 M CHF of net income which accounts for 15.26% change. Track more IVF HARTMANN HOLDING AG CHF1.75 (REGD) financial stats to get the full picture.
Today IVF HARTMANN HOLDING AG CHF1.75 (REGD) has the market capitalization of 333.43 M, it has increased by 3.62% over the last week.
IVF HARTMANN HOLDING AG CHF1.75 (REGD) dividend yield was 2.86% in 2023, and payout ratio reached 50.31%. The year before the numbers were 2.09% and 52.87% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 0QQM shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade IVF HARTMANN HOLDING AG CHF1.75 (REGD) stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 26, 2024, the company has 304.00 employees. See our rating of the largest employees — is IVF HARTMANN HOLDING AG CHF1.75 (REGD) on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So IVF HARTMANN HOLDING AG CHF1.75 (REGD) technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating IVF HARTMANN HOLDING AG CHF1.75 (REGD) stock shows the buy signal. See more of IVF HARTMANN HOLDING AG CHF1.75 (REGD) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. IVF HARTMANN HOLDING AG CHF1.75 (REGD) EBITDA is 22.34 M CHF, and current EBITDA margin is 11.89%. See more stats in IVF HARTMANN HOLDING AG CHF1.75 (REGD) financial statements.